Metenolone


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult : PO Aplastic anaemia As acetate: 100-150 mg/day. IM Postmenopausal osteoporosis As enantate: 100 mg 2 wkly, then reduce to 3-4 wkly after an initial response. Progressive breast cancer As enantate: 100 mg 1-2 wkly or 200 mg 2-3 wkly.
Dosage Details
Intramuscular
Progressive breast cancer
Adult: As enantate: 100 mg every 1-2 wk or 200 mg every 2-3 wk.

Intramuscular
Postmenopausal osteoporosis
Adult: As enantate: 100 mg every 2 wk, then reduce to once every 3-4 wk after an initial response.

Oral
Aplastic anaemia
Adult: As acetate: 100-150 mg/day.
Administration
May be taken with or without food.
Contraindications
Pregnancy. In men, prostate or breast carcinoma, other hormone-dependent carcinoma.
Special Precautions
Lactation; CV disorders, renal or hepatic impairment, epilepsy, migraine, DM, conditions aggravated by fluid retention. Children. Regularly examine prostate in men.
Adverse Reactions
Fluid and electrolyte retention, psychiatric effects, hypercalcaemia, impaired glucose tolerance, increased bone growth and skeletal weight. Men: Impotence, priapism, azoospermia, prostatic hypertrophy; gynaecomastia, hirsutism, male pattern baldness, acne, seborrhoea, oedema, cholestatic jaundice. Women: Virilisation, amenorrhoea, menstrual irregularities, suppressed lactation, increased libido. Children: Premature closure of epiphyses, stops linear growth, virilisation symptoms.
Drug Interactions
May enhance effects of antidiabetics, ciclosporin, levothyroxine, warfarin. Resistance to the effects of neuromuscular blockers may occur.
Lab Interference
May interfere with glucose tolerance and thyroid function tests.
Action
Description: Metenolone is an anabolic steroid, which in high doses stimulates bone marrow functions, particularly erythropoiesis.
Storage
Oral:
Store below 30°C.
Disclaimer: This information is independently developed by MIMS based on Metenolone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Sign up for free
Already a member? Sign in